Soluble Tumor Necrosis Factor Receptor 1 Is Associated with Glomerular Filtration Rate Progression and Incidence of Chronic Kidney Disease in Two Community-Based Cohorts of Elderly IndividualsVise andre og tillknytning
2015 (engelsk)Inngår i: Cardiorenal Medicine, ISSN 1664-3828, Vol. 5, nr 4, s. 278-288Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]
Objective: We aimed to explore and validate the longitudinal associations between soluble tumor necrosis factor receptor 1 (sTNFR1), glomerular filtration rate (GFR) progression, and chronic kidney disease (CKD) incidence in two independent community-based cohorts of elderly individuals with prespecified subgroup analyses in individuals without prevalent diabetes. Research Design and Methods: Two community-based cohorts of elderly individuals were used with 5-year follow-up data on estimated GFR: the Uppsala Longitudinal Study of Adult Men (ULSAM; n = 437 men; mean age: 78 years) and the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS; n = 703; mean age: 70 years; 51% women). GFR categories were defined as >= 60, 30-60, and = 60 ml/min/1.73 m(2) at baseline, higher sTNFRs were associated with incident CKD after 5 years in both cohorts [ULSAM: OR per SD increase 1.49 (95% CI 1.16-1.9) and PIVUS: OR 1.84 (95% CI 1.50-2.26)]. Associations were similar in individuals without diabetes. Conclusions: Higher circulating sTNFR1 independently predicts the progression to a worse GFR category and CKD incidence in elderly individuals even in the absence of diabetes. Further studies are warranted to investigate the underlying mechanisms, and to evaluate the clinical relevance of our findings.
sted, utgiver, år, opplag, sider
2015. Vol. 5, nr 4, s. 278-288
Emneord [en]
Community, TNF-alpha, Glomerular filtration, Albumin/creatinine ratio, Chronic kidney disease, Inflammation
HSV kategori
Identifikatorer
URN: urn:nbn:se:uu:diva-259538DOI: 10.1159/000435863ISI: 000363827900005PubMedID: 26648944OAI: oai:DiVA.org:uu-259538DiVA, id: diva2:844768
Forskningsfinansiär
Swedish Research CouncilSwedish Heart Lung Foundation2015-08-082015-08-082021-11-30bibliografisk kontrollert